Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Hadwan, Mahmoud Hussein
- The effect of Morbid Obesity on the Liver Function Enzymes
Abstract Views :154 |
PDF Views:0
Authors
Affiliations
1 Environmental Research and Studies Centers, Babylon University -51002, IQ
2 Babylon Technical Institute, Al-Furat Al-Awsat Technical University, 51015, Hilla, IQ
3 Chemistry Dept., College of Science, University of Babylon, Iraq, Hilla, IQ
1 Environmental Research and Studies Centers, Babylon University -51002, IQ
2 Babylon Technical Institute, Al-Furat Al-Awsat Technical University, 51015, Hilla, IQ
3 Chemistry Dept., College of Science, University of Babylon, Iraq, Hilla, IQ
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2241-2244Abstract
Background: The liver is the major organ in the body and it is considered as an important organ for protein manufacture and detoxification. Liver health is evaluated by study liver function (LFTs) which include TSB, AST, ALT and ALK. The current study is an attempt to understand the correlation between morbid obesity and liver function enzymes. Method: The research population consisted of 67 subjects that divided into two groups; morbidly obese group (41) and the control group (healthy appearance subjects) (26). The levels of serum liver enzymes activities (ALT, AST, ALK) and TSB were determined by suitable kits. Result: In current study no statistically significant differences were observed in AST, ALT and ALK levels between the two types of procedures. The highest differences were noted for TSB levels between obese and individual healthy. While there was an association between the BMI and both AST and ALT; there was no relationship between the body mass index BMI and TSB and ALK. Conclusion: This study showed a correlation between the BMI with AST and ALT of morbidly obese.Keywords
Obesity, GPT, GOT, ALK, TSB.
References
- Kasarala, G.; and Tillmann, H. L. Standard Liver Tests Clinical Liver Disease 2016; 8(1):13-18.
- Maan W, Warsi AQ, Rashed A, Karjoo M. Unexplained High Activity of Aspartate Aminotransferase in an Asymptomatic Pediatric Patient. Int J Pediatr 2017; 5(10): 5805-5808
- Mauro P, Renze B, Wouter W. Enzymes. In: Tietz text book of clinical chemistry and molecular diagnostics. Carl AB, Edward R, David EB. 4th edition, Elsevier 2006, 604-616.
- Giannini EG, Testa R, Savarino V. Liver Enzyme Alteration: A Guide for Clinicians. CMAJ. 2005;172(3):367–79.
- Lord R, Fahie-Wilson M, Suri S.A Paediatric Case of Macro Aspartate Aminotransferase. Ann Clin Biochem 2008; 45:323-4.
- Yulia. A, Wijesiriwardana. A. Extremely High Isolated Maternal Alkaline Phosphatase Serum Concentration -2 Case Reports. Int J Pregn& Chi Birth 2017; 2(4): 00031
- Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.
- Donaldson MD, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child. 2006;91(6):513-520.
- Meyer, R. E., Thompson, S.J., Addy, C.L., Garrison, C. Z., Best, R.G. Maternal serum placental alkaline phosphatase level and risk forpreterm delivery. Am J ObstetGynecol 1995;173(1): 181-186
- Chang H-C, Yang H-C, Chang H-Y, Yeh C-J, Chen H-H, Huang K-C, et al. Morbid obesity in Taiwan: Prevalence, trends, associated social demographics, and lifestyle factors. PLoS ONE 2017; 12(2): e0169577. doi:10.1371/journal. pone.0169577
- Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity.Annu Rev Immunol 2011;29: 415-45.
- Swınburn BA, Caterson I, Seıdell JC, James WP. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2004;7(1):123-46.
- Álvarez-Castro P, Sangiao-Alvarellos S, Brandón-Sandá I, Cordido F. EndocrinaFuncion in obesity. EndocrinolNutr 2011;58(8):422-32.
- World Health Organization. 2016. Obesity and overweight. Fact sheet No 311. Availableat http:// www.who.int/ mediacentre/ factsheets/ fs311/ en/ (accessed on September 2016).
- Skinner, A. C; Ravanbakht,S. N ;Skelton J. A; Perrin E. M and Armstrong, S. C . Prevalence of Obesity and Severe Obesity in US Children, 1999–2016. Pediatrics. 2018;141(3): e20173459
- Lonardo A, Bellentani S, Ratziu V et al. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient— death of a dogma from analysis of therapeutic studies? Exp Rev GastroenterolHepatol 2011; 5:279–89.
- SalvaggioوA.; Periti, M.; Miano, L.; Tavanelli, M. and Marzorati, D. Body Mass Index and Liver Enzyme Activity in Serum CLINICALCHEMISTRY,1991. 37 (5): 720-723
- Gómez, Z. S; Fernández, Q. A.; Lasa, A.; Hijona, E.; Bujanda, L. and Portillo M.P. Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition. 2013; 29(11-12):1374-80.
- Marchesini, G.; Brizi, M.; Bianchi, G.; Tomassetti, S.; Bugianesi, E.; Lenzi, M.; Mccullough, A.J.;Natale, S.; Forlani, G. and Melchionda N. Nonalcoholic fatty liver disease: a feature of metabolic syndrome. Diabetes. 2001;50(8):1884- 1850.
- Alta’ee AH, Hadwan MH, Almashhedy LA. The balance between superoxide dismutase and catalase activi-ties in sera of obese Iraqi men. Euro Mediterranean Biomedical Journal. 2015;10(17):197-202.
- Lee, J.K.; Shim, J.H. and Lee, H.C et al. Estimation of the healthy upper limits forserum alanine aminotransferase in Asian populations with normal liver histology. Hepatology2010; 51: 1577 – 83.
- Nomura, F.; Ohnishi, K. and Satomura, Y. et al. Liver function in moderate obesity--study in 534 moderately obese subjects among 4613 male company employees. Int J Obes1986; 10: 349 – 54.
- Wejstal, R.; Hansson, G. and Lindholm, A. et al. Persistent alanine amino transferase elevation in healthy Swedish blood donors--mainly caused by obesity. Vox Sang 1988 ; 55 : 152 – 6.
- Piton, A.; Poynard, T .and Imbert-Bismut, F. et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology1998; 27: 1213 – 9
- Flores, Y.N.; Auslander, A.; Crespi, M.C.; Rodriguez, M.; Zhang, Z. F. and Durazo, F. et al.. Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. Journal of digestive diseases. 2016; 17:304-12
- Younossi, Z. M.; Stepanova, M.; Afendy, M.; Fang, Y.; Younossi,Y.; and Mir, H. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2011; 9:524-30.
- Jayanta, P.; Raj Vigna, V.; Lorance, P.;, Shihaz, H.; Kula Naresh, K.S. and Mohit P. Shetti .Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver.2018. disease Gastroenterology Report, 6(1):49–53
- Rohania, F.; Golgiric, F.; Alaeid M. R., Karimie, M.; Nikraftarf, P. and Bozorgmehrf, R. Relationship Between Obesity and Liver Enzymes Levels in Turner’s Syndrome. Gastroenterol Res. 2017;10(1):28-32
- Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.
- El-Mansoury, M.; Berntorp, K.; Bryman,I.; Hanson, C.; Innala, E.; Karlsson, A. and Landin-Wilhelmsen, K. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. ClinEndocrinol (Oxf). 2008;68(3):485-490.
- Wasniewska, M.; Bergamaschi, R.; Matarazzo, P.; Predieri, B.; Bertelloni, S.; Petri, A.; Sposito, M. et al. Increased liver enzymes and hormonal therapies in girls and adolescents with Turner syndrome. J Endocrinol Invest. 2005;28(8):720-726.
- Dufour, D.R.; Lott, J.A.; Nolte, F.S.; Gretch, D.R.; Koff, R.S. and Seeff, L.B. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46:2050–2068.
- Dufour, D. R. Effects of habitual exercise on routine laboratory tests. Clin Chem 1998;44: A136.
- Salerno, M.; Di Maio, S.; Gasparini, N.; Rizzo, M.; F erri, P. and Vajro, P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158(8):618-623.
- Donaldson, M.D.; Gault, E.J.; Tan, K. W. and Dunger, D.B.Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child. 2006;91(6):513-520.
- Willems, A.; Paulson, TA.W.; Keil, M.; Brooke-Wavell, K .and Goosey-Tolfrey, V.L. Dual-Energy X-Ray Absorptiometry, Skinfold Thickness, and Waist Circumferencefor Assessing Body Composition in Ambulant and Non-Ambulant Wheelchair Games Players. Front. Physiol. (2015) 6:356
- Demmer, D.L.; Beilin, L.J; Hands, B. Burrows, S.; Pennell, C.E; Lye, S.J.and et al. Dual Energy XRay Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the ‘Gold Standard’ Tarnished? PLoS ONE. (2016) .11(9): e0162164.
- Precise Spectrophotometric Method for Measurement of Peroxiredoxin Activity in Biological Samples
Abstract Views :150 |
PDF Views:0
Authors
Affiliations
1 Chemistry Dept., Kufa University, Najaf City, Najaf Governorate, IQ
2 Chemistry Dept., College of Science, University of Babylon, Hilla City, Babylon Governorate, P.O. 51002, IQ
1 Chemistry Dept., Kufa University, Najaf City, Najaf Governorate, IQ
2 Chemistry Dept., College of Science, University of Babylon, Hilla City, Babylon Governorate, P.O. 51002, IQ
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2254-2260Abstract
Herein, we describe a simple spectrophotometric method for the measurement of peroxiredoxin activity and demonstrate reproducibility, accuracy, and precision. In these experiments, peroxiredoxin activity was measured by incubating enzyme samples with phosphate buffer solution containing suitable concentrations of the substrates 1,4-dithio-DL-threitol (DTT) and hydrogen peroxide. Titanium sulfate was added to stop enzyme reactions, and subsequent reactions with residual hydrogen peroxide produced pertitanic acid, which was spectrophotometrically measured at 405 nm. Advantages of this method are including the elimination of catalase interference and allowing application of this method to all types of biological tissues. The peroxiredoxin assay is simple and can be completed with few additions. The method is precise, with coefficients of variation of 2.93% within runs and 5.4% between runs. Data from the present peroxiredoxin assay were strongly correlated with those from the ferrous oxidation–xylenol orange (FOX) method (r = 0.9835).Keywords
Peroxiredoxin, Pertitanic Acid, FOX Reagent, Dithiothreitol, H2O2.References
- S. Rhee, H. Chae, K. Kim, Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38 (2005) 1543–1552.
- L. Li, The Relevance of Mammalian Peroxiredoxins to the Gametogenesis, Embryogenesis, and Pregnancy Outcomes. Reproductive Sciences. 24 (2017) 812-817.
- Z.A. Wood, L.B. Poole, P.A. Karplus, Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 300 (2003) 650-653.
- G. Leyens, I. Donnay, B. Knoops, Cloning of bovine peroxiredoxins—gene expression in bovine tissues and amino acid sequence comparison with rat, mouse and primate peroxiredoxins. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 136 (2003) 943-55.
- S. Rhee, S. Kang, T. Chang, W. Jeong, K. Kim, Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35–41.
- T. Ishii, T. Kawane, S. Taketani, S. Bannai, Inhibition of the thiol-specific antioxidant activity of rat liver MSP23 protein by hemin. Biochem Biophys Res Commun 216 (1995) 970–975.
- P. Zhang, B. Liu, S. Kang, M. Seo, S. Rhee, L. Obeid, Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem. 272 (1997) 30615–30618.
- B.B. Horta, M.A. de Oliveira, K.F. Discola, J.R. Cussiol, L.E. Netto, Structural and biochemical characterization of peroxiredoxin Qbeta from Xylella fastidiosa: catalytic mechanism and high reactivity. J. Biol. Chem. 285 (2010) 16051–16065.
- K.S. Yang, S.W. Kang, H.A. Woo, S.C. Hwang, H.Z. Chae, K. Kim, S.G. Rhee, Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277 (2002) 38029–38036.
- K.J. Nelson, D. Parsonage, Measurement of peroxiredoxin activity. Current protocols in toxicology. (2011) 17-10.
- C. Sanchis-Segura, M. Miquel, M. Correa, C.M. Aragon, The catalase inhibitor sodium azide reduces ethanol-induced locomotor activity. Alcohol. 19 (1999) 37-42.
- Y. Aksoy, M. Balk, H. ÖĞÜŞ, N. Özer, The mechanism of inhibition of human erythrocyte catalase by azide, Turkish Journal of Biology. 28 (2005) 65-70.
- M.H. Hadwan, S.K. Ali, New spectrophotometric assay for assessments of catalase activity in biological samples, Analytical biochemistry. 542 (2018) 29-33.
- Y.S. Lim, M.K. Cha, C.H, Yun, H.K. Kim, K.W. Kim, I.H. Kim, Purification and characterization of thiol-specific antioxidant protein from human red blood cell: a new type of antioxidant protein, Biochemical and biophysical research communications. 199 (1994) 199-206.
- T. Eismann, N. Huber, T. Shin, et al., Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice, American Journal of Physiology-Gastrointestinal and Liver Physiology, 296 (2009) G266-G274.
- S. Immenschuh, E. Baumgart-Vogt, M. Tan, et al., Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver, Journal of Histochemistry & Cytochemistry, 51 (2003) 1621-1631.
- S.H. Bae, S.H. Sung, E.J. Cho, et al., Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol‐induced oxidative injury in mouse liver, Hepatology, 53 (2011) 945-53.
- H.I. Choi, S.K. Ma, E.H. Bae, et al., Peroxiredoxin 5 protects TGF-β induced fibrosis by inhibiting Stat3 activation in rat kidney interstitial fibroblast cells, PloS one, 11 (2016) e0149266.
- S.H. Ahn, H.Y. Yang, G.B. Tran, et al., Interaction of peroxiredoxin V with dihydrolipoamide branched chain transacylase E2 (DBT) in mouse kidney under hypoxia, Proteome science, 13 (2015) 4.
- M.B. Pascual, A. Mata-Cabana, F.J. Florencio, Lindahl M, F.J. Cejudo, Overoxidation of 2-Cys Peroxiredoxin in Prokaryotes Cyanobacterial 2-Cys Peroxiredoxins Sensitive to Oxidative Stress, J. Biol. Chem., 285 (2010) 34485-34492.
- S.C. Ferreira, R.E. Bruns, H.S. Ferreira, G.D. Matos, J.M. David, G.C. Brandao, E.P. da Silva, L.A. Portugal, P.S. Dos Reis, A.S. Souza, W.N. Dos Santos, Box-Behnken design: an alternative for the optimization of analytical methods. Analytica chimica acta. 597 (2007) 179-86.
- T.H. Hou, C.H. Su, W.L. Liu, Parameters optimization of a nano-particle wet milling process using the Taguchi method, response surface method and genetic algorithm, Powder technology, 173 (2007) 153-162.
- A.I. Khuri, S. Mukhopadhyay, Response surface methodology. Wiley Interdisciplinary Reviews: Computational Statistics, 2 (2010) 128-149.
- M.A. Bezerra, R.E. Santelli, E.P. Oliveira, L.S. Villar, L.A. Escaleira, Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 76 (2008) 965-977.